Literature DB >> 8756291

The intracellular deletions of Delta and Serrate define dominant negative forms of the Drosophila Notch ligands.

X Sun1, S Artavanis-Tsakonas.   

Abstract

We examined the function of the intracellular domains of the two known Drosophila Notch ligands, Delta and Serrate, by expressing wild-type and mutant forms in the developing Drosophila eye under the sevenless promoter. The expression of intracellularly truncated forms of either Delta (sev-DlTM) or Serrate (sev-SerTM) leads to extra photoreceptor phenotypes, similar to the eye phenotypes associated with loss-of-function mutations of either Notch or Delta. Consistent with the notion that the truncated ligands reduce. Notch signalling activity, the eye phenotypes of sev-DlTM and sev-SerTM are enhanced by loss-of-function mutations in the Notch pathway elements, Notch, Delta, mastermind, deltex and groucho, but are suppressed by a duplication of Delta or mutations in Hairless, a negative regulator of the pathway. These observations were extended to the molecular level by demonstrating that the expression of Enhancer of split m delta, a target of Notch signalling, is down-regulated by the truncated ligands highly expressed in neighbouring cells. We conclude that the truncated ligands act as antagonists of Notch signalling.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8756291     DOI: 10.1242/dev.122.8.2465

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  41 in total

1.  Altered Notch ligand expression in human liver disease: further evidence for a role of the Notch signaling pathway in hepatic neovascularization and biliary ductular defects.

Authors:  Sarbjit S Nijjar; Lorraine Wallace; Heather A Crosby; Stefan G Hubscher; Alastair J Strain
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

2.  Synergy between suppressor of Hairless and Notch in regulation of Enhancer of split m gamma and m delta expression.

Authors:  D S Eastman; R Slee; E Skoufos; L Bangalore; S Bray; C Delidakis
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

Review 3.  Canonical and non-canonical Notch ligands.

Authors:  Brendan D'Souza; Laurence Meloty-Kapella; Gerry Weinmaster
Journal:  Curr Top Dev Biol       Date:  2010       Impact factor: 4.897

4.  Structure-function analysis of delta trafficking, receptor binding and signaling in Drosophila.

Authors:  Annette L Parks; Jane R Stout; Scott B Shepard; Kristin M Klueg; Ana A Dos Santos; Todd R Parody; Martina Vaskova; Marc A T Muskavitch
Journal:  Genetics       Date:  2006-10-08       Impact factor: 4.562

5.  Cross talk between notch and growth factor/cytokine signaling pathways in neural stem cells.

Authors:  Motoshi Nagao; Michiya Sugimori; Masato Nakafuku
Journal:  Mol Cell Biol       Date:  2007-03-19       Impact factor: 4.272

6.  Spectrum and frequency of jagged1 (JAG1) mutations in Alagille syndrome patients and their families.

Authors:  I D Krantz; R P Colliton; A Genin; E B Rand; L Li; D A Piccoli; N B Spinner
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

Review 7.  The many facets of Notch ligands.

Authors:  B D'Souza; A Miyamoto; G Weinmaster
Journal:  Oncogene       Date:  2008-09-01       Impact factor: 9.867

8.  Complex proteolytic processing acts on Delta, a transmembrane ligand for Notch, during Drosophila development.

Authors:  K M Klueg; T R Parody; M A Muskavitch
Journal:  Mol Biol Cell       Date:  1998-07       Impact factor: 4.138

9.  Analysis of dominant enhancers and suppressors of activated Notch in Drosophila.

Authors:  E M Verheyen; K J Purcell; M E Fortini; S Artavanis-Tsakonas
Journal:  Genetics       Date:  1996-11       Impact factor: 4.562

10.  Drosophila Dystroglycan is a target of O-mannosyltransferase activity of two protein O-mannosyltransferases, Rotated Abdomen and Twisted.

Authors:  Naosuke Nakamura; Stephanie H Stalnaker; Dmitry Lyalin; Olga Lavrova; Lance Wells; Vladsilav M Panin
Journal:  Glycobiology       Date:  2009-12-07       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.